<unk>  (TV-3,326) is a novel neuroprotective agent being investigated for the treatment of neurodegenerative disorders like Alzheimer's disease, Lewy body disease, and Parkinson's disease. It acts as a reversible acetylcholinesterase and butyrylcholinesterase inhibitor, and an irreversible monoamine oxidase B inhibitor, and combines the mechanisms of action of older drugs like rivastigmine and rasagiline into a single molecule. In addition to its neuroprotective properties,<unk>  enhances the expression of neurotrophic factors like GDNF and BDNF, and may be capable of reversing some of the damage seen in neurodegenerative diseases via the induction of neurogenesis.<unk>  also has antidepressant effects, and may be useful for treating comorbid depression and anxiety often seen in such diseases as well.
Ladostigil
Truenat
Epiestriol
Ketotifen
Esthiomene
Belumosudil
Penmesterol
Maralixibat chloride